Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genentech
Pharma
Roche's Gazyva secures FDA nod in 2nd autoimmune indication
Gazyva won FDA approval to reduce relapse risk in patients 2 and older with frequently relapsing or steroid-dependent childhood-onset INS.
Donavyn Coffey
Sep 28, 2026 2:29pm
Genentech CMO Zoë Lazarre uses AI as a 'digital backpack'
Sep 22, 2026 2:57pm
Roche reports positive confirmatory trial readout for Lunsumio
Sep 17, 2026 11:25am
Comedian Damon Wayans on humor, relatability and DME awareness
Sep 17, 2026 9:34am
Rising Stars: Genentech’s Tiffany William's pivot to pharma
Sep 2, 2026 3:00am
Roche will invest $750M to build a drug-device plant in Oregon
Aug 20, 2026 3:03pm
